[Rifampicine in tuberculosis. Peculiarity of its experimental activity and new therapeutic prospects].
D000818:Animals; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid / Q000494:pharmacology / Q000627:therapeutic use; D051379:Mice; D008826:Microbial Sensitivity Tests; D009154:Mutation; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D012293:Rifampin / Q000494:pharmacology / Q000627:therapeutic use*; D013307:Streptomycin / Q000494:pharmacology / Q000627:therapeutic use; D013997:Time Factors; D014376:Tuberculosis / Q000188:drug therapy*
D007538:Isoniazid; D012293:Rifampin; D013307:Streptomycin
La rifampicine en tuberculose. Particulairité de son activité expérimentale et nouvelles perspectives thérapeutiques.